Newsletter

Systemic Scleroderma
Nothing in excess is good, not even collagen.
Systemic Scleroderma Market

More Whitepapers / Newsletters

Immune Thrombocytopenic Purpura (ITP)
Immune Thrombocytopenic Purpur...

Immune thrombocytopenic purpura (ITP) is a disorder that results in the immune system killing its platelets. It results in excessive bleeding or bruising easily due to low levels of platelets. Worldwi...

ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies
ASCO Reveals: Increasing Optio...

Immunotherapies, a potentially life-saving therapy, have benefitted several patients suffering from cancer help to achieve complete remission that many other times, traditional chemotherapies fail to...

Remdesivir In COVID-19
Remdesivir In COVID-19

Remdesivir is a broad-spectrum antiviral drug that has previously demonstrated in vitro and in vivo activity against the viral pathogens MERS and SARS, which are also coronaviruses having structural s...

Future Of Medical Imaging
Future Of Medical Imaging

The medical device industry is experiencing rapid change as innovation is accelerating, new business models are evolving, and artificial intelligence and the Internet of Things generate transformative...

Cancer Globally (Vol. 1, Issue 1)
Cancer Globally (Vol. 1, Issue...

There are about 200 different types of cancer, making it one of the most diverse types of indication, afflicting almost all parts of the body. Cancer has a maximum prevalence in Africa, Asia, and Cent...